Schedule 13G ownership disclosure

KALARIS THERAPEUTICS INC

Common Stock, par value $0.0001 per share · CUSIP: 482929106

Event date: 2026-10-19

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Coastlands Capital LP

    Shares: 1,355,119.00 · Class: 5.69%

  • Coastlands Capital Partners LP

    Shares: 1,355,119.00 · Class: 5.69%

  • Coastlands Capital GP LLC

    Shares: 1,355,119.00 · Class: 5.69%

  • Coastlands Capital LLC

    Shares: 1,355,119.00 · Class: 5.69%

  • Matthew D. Perry

    Shares: 1,355,119.00 · Class: 5.69%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-26-118876
Form type
SCHEDULE 13G
Filer
Coastlands Capital LP
CIK
CIK 2068530
Filed
Oct 26, 2026
Reporting period
Oct 19, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub